Photo from wikipedia
Madam, Our current understanding of the COVID-19 virus and its vulnerabilities has not been translated into the approval of its standard line of treatment. COVID-19, although primarily a respiratory ailment,… Click to show full abstract
Madam, Our current understanding of the COVID-19 virus and its vulnerabilities has not been translated into the approval of its standard line of treatment. COVID-19, although primarily a respiratory ailment, may culminate in acute respiratory distress syndrome, hyperinflammatory response, sepsis, and multiorgan failure, which often carry a grave prognosis. Drugs addressing such severities of COVID-19 are often limited by their therapeutic indices, bioavailability, and side effects, necessitating the exploration of new avenues to counter them. The ever-evolving field of nanotechnology presents one such example.
Journal Title: JPMA. The Journal of the Pakistan Medical Association
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!